BioMark Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioMark Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6489
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMark Diagnostics Inc (BioMark Diagnostics) is an oncology-focused medical equipment company that owns and develops multiple intellectual properties in detection and quantitation of metabolites. The company’s advanced near-to- market diagnostic technologies designed to improve patient outcomes. Its products include cancer diagnostic tools, Amantadine, cancer management solutions, biomarkers and others. BioMark Diagnostics offers services such as science of metabolomics research and development, research and technology development, clinical trials, non-imaging cancer detection assays, cell-signaling pathways and others. The company’s products are used in the treatment of cancers including lung, breast, prostate, and GI cancers. BioMark Diagnostics is headquartered in Richmond, British Columbia, Canada.

BioMark Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMark Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMark Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioMark Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMark Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioMark Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioMark Diagnostics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
BioMark Diagnostics Raises USD0.2 Million in Private Placement of Units 10
BioMark Diagnostics Raises USD0.1 Million in Second Tranche of Private Placement of Units 11
BioMark Diagnostics Raises USD0.5 Million in First Tranche of Private Placement of Units 12
BioMark Diagnostics Raises USD0.1 Million in Second Tranche of Private Placement of Units 13
BioMark Diagnostics Raises USD0.3 Million in First Tranche Private Placement of Units 14
BioMark Diagnostics Inc – Key Competitors 15
BioMark Diagnostics Inc – Key Employees 16
BioMark Diagnostics Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
BioMark Diagnostics Inc, Medical Equipment, Key Facts 2
BioMark Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioMark Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMark Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioMark Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMark Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
BioMark Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioMark Diagnostics Raises USD0.2 Million in Private Placement of Units 10
BioMark Diagnostics Raises USD0.1 Million in Second Tranche of Private Placement of Units 11
BioMark Diagnostics Raises USD0.5 Million in First Tranche of Private Placement of Units 12
BioMark Diagnostics Raises USD0.1 Million in Second Tranche of Private Placement of Units 13
BioMark Diagnostics Raises USD0.3 Million in First Tranche Private Placement of Units 14
BioMark Diagnostics Inc, Key Competitors 15
BioMark Diagnostics Inc, Key Employees 16
BioMark Diagnostics Inc, Other Locations 17

List of Figures
BioMark Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioMark Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioMark Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioMark Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioMark Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMark Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioMark Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMark Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BioMark Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes biogeneric drugs, vaccines and biotech products. The company develops products in the areas of oncology, auto-immunity, drug delivery and bio generics. Its products include TBL-0404, TBL-0905, TBL -0 …
  • Cognition Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment …
  • QBE Insurance Group Limited:企業のM&A・事業提携・投資動向
    QBE Insurance Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QBE Insurance Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Logicbio Therapeutics Inc (LOGC):製薬・医療:M&Aディール及び事業提携情報
    Summary Logicbio Therapeutics Inc (Logicbio) is a genome-editing company with focus on the development of transformative medicines for the treatment of hematological and genetic disorders. Its pipeline product candidates include LB-101 for treating Hemophilia B; LB-201 against inborn error of metabo …
  • Convergys Corporation:企業の戦略・SWOT・財務情報
    Convergys Corporation - Strategy, SWOT and Corporate Finance Report Summary Convergys Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Immuron Ltd (IMC)-製薬・医療分野:企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …
  • MegaChips Corp (6875):企業の財務・戦略的SWOT分析
    MegaChips Corp (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BB Biotech AG (BION):企業の財務・戦略的SWOT分析
    Summary BB Biotech AG (BB Biotech) operates as a financial service provider that offers biotechnology investments. The company invests in markets that develop new drugs and therapies for use in the treatment of autoimmune and infectious diseases, oncology disorders, cardiovascular diseases, and meta …
  • Menasha Corporation:企業の戦略・SWOT・財務分析
    Menasha Corporation - Strategy, SWOT and Corporate Finance Report Summary Menasha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HealthTronics Inc:企業の戦略的SWOT分析
    HealthTronics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Total Produce plc:企業の戦略・SWOT・財務分析
    Total Produce plc - Strategy, SWOT and Corporate Finance Report Summary Total Produce plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PetroChina Company Limited:企業の戦略・SWOT・財務情報
    PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report Summary PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Avadel Pharmaceuticals Plc (AVDL):製薬・医療:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • Magnus Life Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Magnus Life Ltd (Magnus) is a biomedical organization that funds, builds and manages companies to translate science into therapeutics and devices. The organization in involved in developing therapies for the treatment for obstetric conditions and pathologies of pregnancy including placental …
  • Centrus Energy Corp.:企業の戦略・SWOT・財務情報
    Centrus Energy Corp. - Strategy, SWOT and Corporate Finance Report Summary Centrus Energy Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mudman Public Company Limited (MM):企業の財務・戦略的SWOT分析
    Mudman Public Company Limited (MM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Essential Energy:企業の戦略的SWOT分析
    Essential Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • NRG Energy Inc (NRG)-エネルギー分野:企業M&A・提携分析
    Summary NRG Energy, Inc. (NRG) is an integrated energy company that produces, sells and delivers energy, and energy products and services. The company generates power using diverse sources such as coal, natural gas, nuclear, oil, wind and solar. It trades wholesale energy, capacity, fuel and related …
  • Odakyu Electric Railway Co., Ltd.:企業の戦略・SWOT・財務情報
    Odakyu Electric Railway Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Odakyu Electric Railway Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆